HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sunil K Dhar Selected Research

salicylhydroxamic acid (SHAM)

10/2008Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sunil K Dhar Research Topics

Disease

5Heart Failure
10/2011 - 10/2008
2Hypertrophy
07/2011 - 10/2008
1Hypertension (High Blood Pressure)
10/2011
1Renal Hypertension
10/2011
1Renal Insufficiency (Renal Failure)
10/2011
1Ischemia
04/2011
1Systolic Heart Failure
07/2010
1Myocardial Infarction
10/2009
1Cardiomegaly (Heart Hypertrophy)
10/2008
1Ventricular Remodeling
10/2008

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
07/2011 - 04/2011
2CollagenIBA
07/2011 - 10/2008
1CK 2018448IBA
10/2011
1Antihypertensive Agents (Antihypertensives)IBA
10/2011
1Myosins (Myosin)IBA
10/2011
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
10/2011
1Amlodipine (Norvasc)FDA LinkGeneric
10/2011
1Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2011
1Arginine (L-Arginine)FDA Link
04/2011
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2011
1omecamtiv mecarbilIBA
07/2010
1Cardiac MyosinsIBA
07/2010
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
10/2009
1salicylhydroxamic acid (SHAM)IBA
10/2008
1epoxomicinIBA
10/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2008

Therapy/Procedure

1Oral Administration
10/2011
1Therapeutics
07/2010